Clinical Trials Browser

Phase 2 × Withdrawn × gallium citrate × Clear all

NCT02776891 2019-10-10

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

Phase 2 Withdrawn

Burkitt Lymphoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse